Centene Corporation
Centene Corporation (CNC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cnc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Centene Corporation (CNC) measures how much investors pay for each dollar of the company's trailing earnings. CNC's current PE ratio of N/A is calculated by dividing its stock price of $64.72 by its TTM earnings per share of -$13.09.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 18 fiscal years · Front-end computedMinQ1 · 25%19.1x
MedianQ3 · 75%1055.9x
Max
At N/A, CNC's current P/E is lower than in 0% of its annual fiscal year readings over the past 18 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Plans · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Centene CorporationYou CNC | $32.0B | N/A | — | -$13.09 |
 Fresenius Medical Care AG & Co. KGaA FMS | $11.7B | 12.07x | -48.6% | $1.68 |
 Genmab A/S GMAB | $15.2B | 19.86x | -15.5% | $1.55 |
 Hologic, Inc. HOLX | $17.0B | 26.99x | +14.9% | $2.49 |
 Illumina, Inc. ILMN | $23.9B | 24.52x | +4.3% | $5.48 |
 Medpace Holdings, Inc. MEDP | $13.0B | 35.91x | +52.8% | $15.64 |
 Royalty Pharma plc RPRX | $23.8B | 21.65x | -7.9% | $1.79 |
Industry Average 6 peers with valid PE | — | 23.50x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-13.59 | — | |
2024-12-31 FY2024 | 9.56x | $6.33 | -35.9% | |
2023-12-31 FY2023 | 14.92x | $4.97 | -62.0% | |
2022-12-31 FY2022 | 39.24x | $2.09 | +10.1% | |
2021-12-31 FY2021 | 35.65x | $2.31 | +88.2% | |
2020-12-31 FY2020 | 18.95x | $3.17 | -3.7% | |
2019-12-31 FY2019 | 19.68x | $3.19 | -21.3% | |
2018-12-31 FY2018 | 25.00x | $2.31 | +18.9% | |
2017-12-31 FY2017 | 21.02x | $2.40 | +31.0% | |
2016-12-31 FY2016 | 16.04x | $1.76 | -27.3% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Centene Corporation (CNC) measures how much investors pay for each dollar of the company's trailing earnings. CNC's current PE ratio of N/A is calculated by dividing its stock price of $64.72 by its TTM earnings per share of -$13.09.
Frequently asked questions
CNC pe ratio · 6 questionsCNC's current PE ratio is N/A as of 2026-06-08, based on a stock price of $64.72 and TTM EPS of -$13.09. Data sourced from Financial Modeling Prep via CNC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Centene Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08